Issue Date | Title | Author(s) |
2011 | Empirically-Sourced Mechanical Behaviors of Pneumatic Artificial Muscles for Compensation-Based Controls | Fei, Li; Yu, Wang; Heting, Tong; Han, Ray P. S. |
2016 | Hazard degree assessment of coastal erosion at Tianlongsi adjacent sandy coast | Wen, Shiyong; Fengshou, Zhang; Xiang, Wang; Zizhu, Wang; Fei, Li; Fei, Wang; Xinxin, Wang; Xu, Xuegong |
15-Nov-2022 | Is the 2nd Generation Tyrosine Kinase-Inhibitor a Better Initial Therapy Than Imatinib in Persons with Chronic Myeloid Leukemia Presenting in Accelerated Phase: A Multicenter Retrospective Study | Yang, Sen; Zhang, Xiaoshuai; Zhang, Yanli; Du, Xin; Weng, Jianyu; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Meng, Li; Liu, Zhenfang; Liu, Xiaoli; Xu, Na; Chen, Chunyan; Wang, Xiaodong; Liang, Rong; Huang, Jian; Li, Guohui; Liu, Chunshui; Lin, Hai; Hu, Jianda; Fei, Li; Liu, Bingcheng; Li, Weiming; Liu, Zhuogang; Yang, Wei; Huang, Xiao Jun; Jiang, Qian |
15-Nov-2022 | A Predictive Scoring System for Therapy Failure in Persons with Chronic Myeloid Leukemia Receiving Initial a Second-Generation Tyrosine Kinase Inhibitor Therapy | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Gongli; Liu, Xiaoli; Xu, Na; Li, Weiming; Du, Xin; Weng, Jianyu; Lin, Hai; Liang, Rong; Chen, Chunyan; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Fei, Li; Yang, Wei; Meng, Li; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |
15-Nov-2022 | Study of the Anti-Btla Antibody Tifcemalimab As a Single Agent or in Combination with Toripalimab in Relapsed/Refractory Lymphomas | Ma, Jun; Song, Yuqin; Xie, Yan; Zhang, Hui-Lai; Shuang, Yuerong; Peng, Zhigang; Fei, Li; Huang, Yunhong; Zhao, Weili; Huang, Wenrong; Pan, Yali; Liu, Mingying; Ran, Feiwu; Feng, Hui; Yao, Sheng; Keegan, Patricia; Zou, Jianjun; Zhu, Jun |
15-Nov-2022 | Subjects with Chronic Myeloid Leukemia Identified As Intermediate- or High-Risk Subjects Using the Imatinib Therapy Failure (IMTF) Model Benefit from Initial Therapy with a Second-Generation Tyrosine Kinase Inhibitor | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Gongli; Liu, Xiaoli; Xu, Na; Li, Weiming; Du, Xin; Weng, Jianyu; Lin, Hai; Liang, Rong; Chen, Chunyan; Zhu, Huanling; Pan, Ling; Yang, Yun-fan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Fei, Li; Yang, Wei; Meng, Li; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |
15-Nov-2022 | Validation and Use of Predictive Scoring Systems for Molecular Responses in 5,203 Persons with Chronic Myeloid Leukemia | Zhang, Xiaoshuai; Liu, Bingcheng; Huang, Jian; Zhang, Gongli; Liu, Xiaoli; Xu, Na; Li, Weiming; Du, Xin; Weng, Jianyu; Lin, Hai; Liang, Rong; Chen, Chunyan; Zhu, Huanling; Pan, Ling; Yang, Yunfan; Wang, Xiaodong; Li, Guohui; Liu, Zhuogang; Liu, Zhenfang; Hu, Jianda; Liu, Chunshui; Fei, Li; Yang, Wei; Meng, Li; Gale, Robert Peter; Huang, Xiao Jun; Jiang, Qian |